Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2008
11/20/2008WO2007100902A3 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
11/20/2008WO2007098393A3 Compounds and methods for treating diseases with trpv4 channel receptors
11/20/2008WO2007095187A3 Compositions and methods for antibiotic potentiation and drug discovery
11/20/2008WO2007092329A9 Pharmaceutical compositions for treating depression, anxiety and neurodegenerative disorders
11/20/2008WO2007087266A3 Methods and compositions of targeted drug development
11/20/2008WO2007078815A3 Certain chemical entities, compositions, and methods
11/20/2008WO2007075849A3 Treatment methods using triaryl methane compounds
11/20/2008WO2007075800A3 Methods and systems for the delivery of corticosteroids
11/20/2008WO2007075798A3 Methods and systems for the delivery of corticosteroids having an increased lung deposition
11/20/2008WO2007075524A3 Substituted piperidines as calcium channel blockers
11/20/2008WO2007075408A3 Effervescent compositions for triptans
11/20/2008WO2007075381A3 Pharmaceutical compositions of ilaprazole
11/20/2008WO2007075377A3 Certain chemical entities, compositions and methods
11/20/2008WO2007075077A8 Use of transcriptome-modifying agents and chemotherapy or radiotherapy against cancer
11/20/2008WO2007070701A3 Compositions and methods for preserving brain function
11/20/2008WO2007070683A3 Certain chemical entities, compositions and methods
11/20/2008WO2007056539A3 Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy
11/20/2008WO2007034445A3 Novel piperazine derivatives as renin inhibitors for cardiovascular events and renal insufficiency
11/20/2008WO2004087055A3 Use of fgf- 18 protein, target proteins and their respective encoding nucleotide sequences to induce cartilage formation
11/20/2008WO2003061577A8 Polyalkylene glycol with moiety for conjugating biologically active compound
11/20/2008US20080289065 Peptide Aptamers That Bind to the Rep Proteins of Ssdna Viruses
11/20/2008US20080289058 Targeted delivery of glycine receptors to excitable cells
11/20/2008US20080289057 Sperm factor sequences
11/20/2008US20080287879 system and method for treating erectile dysfunction
11/20/2008US20080287866 Methods and compositions for the treatment of pain
11/20/2008US20080287674 Inhibitors of Factor XA and Other Serine Proteases Involved in the Coagulation Cascade
11/20/2008US20080287671 2'(3')-O-((Phenylaminocarbonyl)-uridine 5'-)triphosphate, for example; useful in preventing thrombosis and restenosis, effective in inhibiting the contraction of vascular smooth muscle cells, inhibiting cell proliferation, and reducing inflammation
11/20/2008US20080287550 Sertraline hydrochloride form II and methods for the preparation thereof
11/20/2008US20080287549 Methods and materials for controlling rodent populations
11/20/2008US20080287548 Compositions and Methods For Inhibiting an Isoform of Human Manganese Superoxide Dismutase
11/20/2008US20080287547 Glycine Transport Inhibitors
11/20/2008US20080287546 Quorum Sensing Modulators
11/20/2008US20080287545 Use of Peptide Compounds For the Prophylaxis and Treatment of Chronic Headache
11/20/2008US20080287544 Method for Screening Substance by Measuring PPAR DELTA Activating Effect and Agent
11/20/2008US20080287543 Pharmaceutical composition comprising 5-methyl-2 (2'-chloro-6'-fluoroanillino) phen ylacetic acid
11/20/2008US20080287542 Novel Isovaleramide Forms, Compositions Thereof, and Related Methods of Use
11/20/2008US20080287541 Kit for Treatment of Cancer
11/20/2008US20080287540 Lip care compositions
11/20/2008US20080287539 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause
11/20/2008US20080287538 Antimicrobial Compositions and Methods
11/20/2008US20080287537 Composition, Particularly a Cosmetic Composition, Comprising ((Dialkylamino)Alkoxy) Ethanol Ester
11/20/2008US20080287536 Topical applying; acne; alopecia
11/20/2008US20080287533 Ascorbic Acid - Natural Sugar Lactone Esters for Comprehensive Skin & Scalp Care
11/20/2008US20080287532 Oxacyclopentene-2 derivatives
11/20/2008US20080287531 Preventive and/or Therapeutic Agent for Sleeping Disorder
11/20/2008US20080287530 Tripolide Lactone Ring Derivatives as Immunomodulators and Anticancer Agents
11/20/2008US20080287529 Crystal structures of sglt2 inhibitors and processes for preparing same
11/20/2008US20080287528 Therapeutic methods and compositions involving isoflavones
11/20/2008US20080287527 Comprising hydroxymorusin, Cortex Mori (White Mulberry root-bark), for use in manufacturing antibacterial medicaments or oral care products; treatment of caries and periodontal disease
11/20/2008US20080287526 Pharmaceuticals for treating or preventing oral diseases
11/20/2008US20080287525 Pharmaceuticals for treating or preventing oral diseases
11/20/2008US20080287524 Method of Purifying a Surfactant by Ultrafiltration
11/20/2008US20080287523 Pyrrolidin-3-Yl Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
11/20/2008US20080287522 reduced or no emetogenic effects ; benzylated phosphodiesterase 4 inhibitors; e.g. Rolipram, Ariflo, Arofylline; preparation by benzylation using benzyl bromide or a derivative; antiinflammatory agents; to treat autoimmune diseases; cystic fibrosis
11/20/2008US20080287521 Crystalline Forms Of [R-(R*,R*)-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methyl- Ethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic Acid Calcium Salt (2:1)
11/20/2008US20080287520 Use of Melatonin in Preventing Postoperative Complications
11/20/2008US20080287519 Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide
11/20/2008US20080287518 Use of a Benzoyl Derivative of 3-Aminocarbazole For the Treatment of a Disorder Associated With the Production of Prostaglandin E2 (Pge2)
11/20/2008US20080287517 Pyrazole Derivatives as Cb1 Modulators
11/20/2008US20080287516 Phenyl-Substituted Pyrrolidones
11/20/2008US20080287515 Aqueous compositions containing solubilized metronidazole at a concentration of 0.75% by weight or greater are obtained by using combination of solubility enhancing agents, one of which is niacinamide and the other is hydroxyalkyl urea; treatment of dermal and mucosal disorders, for example, rosacea
11/20/2008US20080287514 Aqueous compositions containing solubilized metronidazole at a concentration of 0.75% by weight or greater are obtained by using combination of solubility enhancing agents, one of which is niacinamide and the other is hydroxyalkyl urea; treatment of dermal and mucosal disorders, for example, rosacea
11/20/2008US20080287513 Topical compositions containing metronidazole
11/20/2008US20080287511 Anthelmintic Imidazol-Thiazole Derivates
11/20/2008US20080287510 Novel compounds as cannabinoid receptor ligands
11/20/2008US20080287509 Pharmaceutical Composition for the Treatment of Bone Fracture
11/20/2008US20080287508 Altering pharmacokinetics of pirfenidone therapy
11/20/2008US20080287507 Nicotine containing toiletry waters
11/20/2008US20080287505 Substituted 2-methyl-2-phenoxy-n-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
11/20/2008US20080287504 Such as N-(4-Fluoro-benzyl)-4-(3-phenyl-indole-1-sulfonyl)-benzamide; Cannabinoid-1 (CB1) receptor; dietetics
11/20/2008US20080287503 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
11/20/2008US20080287502 Transdermal Administration of Proton Pump Inhibitors
11/20/2008US20080287501 Therapeutic uses of an insulin secretion enhancer
11/20/2008US20080287500 Diastereomers of 4-aryloxy-3-hydroxypiperidines
11/20/2008US20080287499 N-deacetylthiocolchicine deriatives, their use and pharmaceutical formulations containing them
11/20/2008US20080287498 Optically active isomers of ketotifen and therapeutically active metabolites thereof
11/20/2008US20080287497 Transdermal methods and systems for the delivery of anti-migraine compounds
11/20/2008US20080287496 1-Oxo- and 1,3-dioxoisoindolines and method of reducing inflammatory cytokine levels
11/20/2008US20080287495 Novel benzo[d][1,3]-dioxol derivatives
11/20/2008US20080287494 Transmucosal treatment methods in patients with mucositis
11/20/2008US20080287493 Arylmethylen substituted n-acyl-y-aminoalcohols
11/20/2008US20080287492 Alkylpyridyl Quinolines as Nk3 Receptor Modulators
11/20/2008US20080287491 Tetrahydroquinoline Derivative for Treating Nicotine Craving
11/20/2008US20080287490 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
11/20/2008US20080287489 Ophthalmic compositions for treating ocular hypertension
11/20/2008US20080287488 Use of a Sulfonamide Compound For Improving the Pharmacokinetics of a Drug
11/20/2008US20080287487 Muscle relaxants; respiratory system disorders; asthma; COPD; emphysema; bronchitis
11/20/2008US20080287486 Prokinetic agent for bowel preparation
11/20/2008US20080287485 Novel indolizine derivatives, method for preparing same, and therapeutic compositions comprising same
11/20/2008US20080287484 Neurotrophin antagonist compositions
11/20/2008US20080287483 Polyketides and Their Synthesis and Use
11/20/2008US20080287482 Production of Polyketides and Other Natural Products
11/20/2008US20080287481 Process for the preparation of desloratadine polymorph mixtures
11/20/2008US20080287480 Therapeutic Combination Comprising a Nmda Receptors Blocker and a Narcotic Analgesic Substance
11/20/2008US20080287479 Inhibitors of serine palmitoyltransferase
11/20/2008US20080287478 Nociceptin Analogues and Uses Thereof
11/20/2008US20080287477 Novel Compounds as Modulators of Ppar
11/20/2008US20080287476 Administration of dipeptidyl peptidase inhibitors
11/20/2008US20080287475 4-(3-Aminopyrazole) Pyrimidine Derivatives for Use as Tyrosine Kinase Inhibitors in the Treatment of Cancer
11/20/2008US20080287474 Antiproliferative Pyrimidyl, Fused Pyrimidyl and Pyrimidyl Hydrazones
1 ... 2986 2987 2988 2989 2990 2991 2992 2993 2994 2995 2996 2997 2998 2999 3000 3001 3002 3003 3004 3005 3006 ... 7860